Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis Patients

References

• Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758–764. doi:10.1093/aje/kwv25426994063
   PubMed Web of Science ®Google Scholar
• Young JG, Cain LE, Robins JM, O’Reilly EJ, Hernán MA. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci. 2011;3(1):119–143. doi:10.1007/s12561-011-9040-724039638
   PubMedGoogle Scholar
• Robins J. A new approach to causal inference in mortality studies with a sustained exposure period - application to control of the healthy worker survivor effect. Math Model. 1986;7(9–12):1393–1512. doi:10.1016/0270-0255(86)90088-6
   Web of Science ®Google Scholar
• Hernán MA, Robins JM. Causal Inference. Boca Raton: Chapman & Hall/CRC, forthcoming; 2019.
   Google Scholar
• Daniel RM, Cousens SN, De Stavola BL, Kenward MG, Sterne JAC. Methods for dealing with time-dependent confounding. Stat Med. 2013;32(9):1584–1618. doi:10.1002/sim.568623208861
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Greenland S, Lash TJ. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014.
   Google Scholar
• Bailie GR, Larkina M, Goodkin DA, et al. Data from the dialysis outcomes and practice patterns study validate an association between high intravenous iron doses and mortality. Kidney Int. 2015;87(1):162–168. doi:10.1038/ki.2014.27525075769
   PubMed Web of Science ®Google Scholar
• Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Liu J, Winkelmayer WC. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010;303(9):857–864. doi:10.1001/jama.2010.20620197532
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Regidor DL, McAllister CJ, Beckie M, Warnock DG. Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16(10):3070–3080. doi:10.1681/ASN.200504042316033854
   PubMed Web of Science ®Google Scholar
• Feldman HI, Joffe M, Robinson BM, et al. Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol. 2004;15(6):1623–1632. doi:10.1097/01.ASN.0000128009.69594.BE15153574
   PubMed Web of Science ®Google Scholar
• Miskulin DC, Tangri N, Bandeen-Roche K, et al. Intravenous iron exposure and mortality in patients on hemodialysis. Clin J Am Soc Nephrol. 2014;9(11):1930–1939. doi:10.2215/CJN.0337041425318751
   PubMed Web of Science ®Google Scholar
• Tangri N, Miskulin DC, Zhou J, et al. Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. Nephrol Dial Transplant. 2015;30(4):667–675. doi:10.1093/ndt/gfu34925366328
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis. 2009;16(2):143–151. doi:10.1053/j.ackd.2008.12.00819233073
   PubMed Web of Science ®Google Scholar
• Coyne DW. Iron indices: what do they really mean? Kidney Int. 2006;69(Suppl101):S4–8. doi:10.1038/sj.ki.5000404
   Web of Science ®Google Scholar
• Macdougall IC, White C, Anker SD, et al. Intravenous iron in patients undergoing maintenance hemodialysis. N Engl J Med. 2018;380(5):447–458. doi:10.1056/NEJMoa181074230365356
   PubMed Web of Science ®Google Scholar
• Karaboyas A, Morgenstern H, Pisoni RL, et al. Association between serum ferritin and mortality: findings from the USA, Japan and European dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 2018;33(12):2234–2244. doi:10.1093/ndt/gfy19030010940
   PubMed Web of Science ®Google Scholar
• Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The dialysis outcomes and practice patterns study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004;44:S7–15. doi:10.1016/S0272-6386(04)01099-6
   PubMed Web of Science ®Google Scholar
• Young EW, Goodkin DA, Mapes DL, et al. The dialysis outcomes and practice patterns study (DOPPS): an international hemodialysis study. Kidney Int. 2000;57(Suppl74):S74–81. doi:10.1046/j.1523-1755.2000.07413.x
   Web of Science ®Google Scholar
• Macdougall IC, White C, Anker SD, et al. Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): study design and baseline data. Am J Nephrol. 2018;48(4):260–268. doi:10.1159/00049355130304714
   PubMed Web of Science ®Google Scholar
• Lodi S, Phillips A, Lundgren J, et al. Effect estimates in randomized trials and observational studies: comparing apples with apples. Am J Epidemiol. 2019;188(8):1569–1577. doi:10.1093/aje/kwz10031063192
   PubMed Web of Science ®Google Scholar
• Cole SR, Richardson DB, Chu H, Naimi AI. Analysis of occupational asbestos exposure and lung cancer mortality using the G formula. Am J Epidemiol. 2013;177(9):989–996. doi:10.1093/aje/kws34323558355
   PubMed Web of Science ®Google Scholar
• Schomaker M, Heumann C. Bootstrap inference when using multiple imputation. Stat Med. 2018;37(14):2252–2266. doi:10.1002/sim.765429682776
   PubMed Web of Science ®Google Scholar
• Karaboyas A, Morgenstern H, Li Y, et al. Estimating the fraction of first-year hemodialysis deaths attributable to potentially modifiable risk factors: results from the DOPPS. Clin Epidemiol. 2020;12:51–60. doi:10.2147/CLEP.S23319732021471
   PubMed Web of Science ®Google Scholar
• Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38(6):1599–1611. doi:10.1093/ije/dyp19219389875
   PubMed Web of Science ®Google Scholar
• Westreich D, Cole SR, Young JG, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012;31(18):2000–2009. doi:10.1002/sim.531622495733
   PubMed Web of Science ®Google Scholar
• Keil AP, Edwards JK, Richardson DB, Naimi AI, Cole SR. The parametric g-formula for time-to-event data: intuition and a worked example. Epidemiology. 2014;25(6):889–897. doi:10.1097/EDE.000000000000016025140837
   PubMed Web of Science ®Google Scholar
• Zhang Y, Young JG, Thamer M, Hernán MA. Comparing the effectiveness of dynamic treatment strategies using electronic health records: an application of the parametric g-formula to anemia management strategies. Health Serv Res. 2018;53(3):1900–1918. doi:10.1111/1475-6773.1271828560811
   PubMed Web of Science ®Google Scholar
• United States Renal Data System. 2018 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD; 2018.
   Google Scholar
• Munafò MR, Nosek BA, Bishop DVM, et al. A manifesto for reproducible science. Nat Hum Behav. 2017;1(1):1–9. doi:10.1038/s41562-016-0021
   Web of Science ®Google Scholar
• Alahdab F, Farah W, Almasri J, et al. Treatment effect in earlier trials of patients with chronic medical conditions: a meta-epidemiologic study. Mayo Clin Proc. 2018;93(3):278–283. doi:10.1016/j.mayocp.2017.10.02029477781
   PubMed Web of Science ®Google Scholar
• Li X, Cole SR, Kshirsagar AV, Fine JP, Stürmer T, Brookhart MA. Safety of dynamic intravenous iron administration strategies in hemodialysis patients. Clin J Am Soc Nephrol. 2019;14(5):728–737. doi:10.2215/CJN.0397031830988164
   PubMed Web of Science ®Google Scholar
• US-DOPPS Practice Monitor (DPM). 4 2019 [cited 911, 2019]. Available from: https://www.dopps.org/DPM/.
   Google Scholar
• Collister D, Tangri N. Post-PIVOTAL iron dosing with maintenance hemodialysis. Clin J Am Soc Nephrol. 2019;14(10):1533–1535. doi:10.2215/CJN.0230021931182556
   PubMed Web of Science ®Google Scholar
• Coyne DW, Kapoian T, Suki W, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the dialysis patients’ response to IV iron with elevated ferritin (DRIVE) study. J Am Soc Nephrol. 2007;18(3):975–984. doi:10.1681/ASN.200609103417267740
   PubMed Web of Science ®Google Scholar
• Bazeley J, Bieber BA, Li Y, et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(10):2452–2461. doi:10.2215/CJN.0071011121868617
   PubMed Web of Science ®Google Scholar
• Westreich D, Cole SR. Invited commentary: positivity in practice. Am J Epidemiol. 2010;171(6):674–677. doi:10.1093/aje/kwp43620139125
   PubMed Web of Science ®Google Scholar
• Newsome SJ, Keogh RH, Daniel RM. Estimating long-term treatment effects in observational data: a comparison of the performance of different methods under real-world uncertainty. Stat Med. 2018;37(15):2367–2390. doi:10.1002/sim.766429671915
   PubMed Web of Science ®Google Scholar
• Hernán MA, Robins JM. Per-protocol analyses of pragmatic trials. N Engl J Med. 2017;377(14):1391–1398. doi:10.1056/NEJMsm160538528976864
   PubMed Web of Science ®Google Scholar
• Bartlett VL, Dhruva SS, Shah ND, Ryan P, Ross JS. Feasibility of using real-world data to replicate clinical trial evidence. JAMA Netw open. 2019;2(10):e1912869. doi:10.1001/jamanetworkopen.2019.1286931596493
   PubMed Web of Science ®Google Scholar